Quidel | QDEL - Equity Capital And Reserves


Quidel reported $1.92B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Agilent USD 6.91B 167M Dec/2025
Avanos Medical USD 778.2M 200K Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Bruker USD 2.49B 625.6M Sep/2025
Cerus USD 61.46M 6.04M Sep/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Haemonetics USD 911.45M 62.28M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Illumina USD 2.72B 342M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Merit Medical Systems USD 1.58B 54.9M Dec/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Myriad Genetics USD 368M 4.8M Dec/2025
Neogen USD 2.1B 14.16M Sep/2025
OraSure Technologies USD 340.83M 21.15M Dec/2025
Pacific Biosciences Of California USD 5.35M 30.74M Dec/2025
Quidel USD 1.92B 115.9M Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
STAAR Surgical USD 344.18M 9.6M Dec/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Waters USD 2.56B 230.55M Dec/2025